BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29342266)

  • 1. Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.
    Elhassan YS; Idkowiak J; Smith K; Asia M; Gleeson H; Webster R; Arlt W; O'Reilly MW
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1214-1223. PubMed ID: 29342266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal children.
    Idkowiak J; Elhassan YS; Mannion P; Smith K; Webster R; Saraff V; Barrett TG; Shaw NJ; Krone N; Dias RP; Kershaw M; Kirk JM; Högler W; Krone RE; O'Reilly MW; Arlt W
    Eur J Endocrinol; 2019 Mar; 180(3):213-221. PubMed ID: 30566905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).
    Kumar A; Woods KS; Bartolucci AA; Azziz R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):644-9. PubMed ID: 15943823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C; Reyna R; Boots LS; Azziz R
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization.
    Sir-Petermann T; Maliqueo M; Angel B; Lara HE; Pérez-Bravo F; Recabarren SE
    Hum Reprod; 2002 Oct; 17(10):2573-9. PubMed ID: 12351531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.
    Pinola P; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Ruokonen A; Puukka K; Tapanainen JS; Morin-Papunen LC
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3400-7. PubMed ID: 26192874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to androgen excess in women: Clinical and biochemical insights.
    Cussen L; McDonnell T; Bennett G; Thompson CJ; Sherlock M; O'Reilly MW
    Clin Endocrinol (Oxf); 2022 Aug; 97(2):174-186. PubMed ID: 35349173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome.
    Kępczyńska-Nyk A; Kuryłowicz A; Nowak A; Bednarczuk T; Ambroziak U
    J Endocrinol Invest; 2021 Mar; 44(3):505-513. PubMed ID: 32557272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
    Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Years.
    Carmina E; Longo RA
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
    O'Reilly MW; Taylor AE; Crabtree NJ; Hughes BA; Capper F; Crowley RK; Stewart PM; Tomlinson JW; Arlt W
    J Clin Endocrinol Metab; 2014 Mar; 99(3):1027-36. PubMed ID: 24423344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus.
    Andræ F; Abbott D; Stridsklev S; Schmedes AV; Odsæter IH; Vanky E; Salvesen Ø
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3762-70. PubMed ID: 32866967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is acne a sign of androgen excess disorder or not?
    Uysal G; Sahin Y; Unluhizarci K; Ferahbas A; Uludag SZ; Aygen E; Kelestimur F
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():21-25. PubMed ID: 28178574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.